Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Alberta Cellular and Immunotherapy (ACIT) 001, Updated Results of Decentralized Production of Second Generation, Anti-CD19/41BB/CD3z Chimeric Antigen Receptor (CAR) T-Cells in Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL)

Michael P. Chu, Zack Breckenridge, Deanna Hockley, Mona Shafey, Sunil J. Desai, Victor A. Lewis, Peng Wang, Vladimir Sapon-Cousineau, Charles Yin, Carina Debes-Marun, Irwindeep Sandhu

Blood (2024) 144 (Supplement 1): 3464.

https://doi.org/10.1182/blood-2024-209646

Published: 2024

Journal Articles

Outcome of Infants Treated on Total Therapy for Infants with Acute Lymphoblastic Leukemia I: Results from a Non-Randomized Multi-Center Study

Blood (2023) 142 (Supplement 1): 823.

https://doi.org/10.1182/blood-2023-177798

Published: 2023

Journal Articles

Alberta Cellular and Immunotherapy (ACIT) 001, Results of Decentralized Production of Second Generation, Anti-CD19/41BB/CD3z Chimeric Antigen Receptor (CAR) T-Cells in Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL)

Michael P. Chu, Zack M. Breckenridge, Andrew Daly, Mona Shafey, Victor A. Lewis, Sunil J. Desai, Peng Wang, Joseph Brandwein, Peter Duggan, Beverly Wilson, Bindu Thapa, Carina Debes-Marun, Irwindeep Sandhu

Blood (2022) 140 (Supplement 1): 7466–7467.

https://doi.org/10.1182/blood-2022-165887

Published: 2022

Journal Articles

Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease

Blood (2022) 139 (2): 287–299.

https://doi.org/10.1182/blood.2021013244

Published: 2022

Includes: Supplemental data

Journal Articles

Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-139031

Published: 2020

Journal Articles

A Novel Anti-Cancer Vaccine Approach for the Treatment of High-Risk Leukemia in Children

Thakur Satbir, PhD, Son Tran, Mohit Jain, PhD, Austin Lewis, Luis Murguia-Favela, MD, Faisal M Khan, PhD D (ABHI), Kevin J. Bielamowicz, MD, Olena Vaske, PhD, Victor A. Lewis, MD, Norman J. Lacayo, MD, Aru Narendran, MD PhD

Blood (2020) 136 (Supplement 1): 25.

https://doi.org/10.1182/blood-2020-143381

Published: 2020

Journal Articles

Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies

Blood (2020) 135 (15): 1287–1298.

https://doi.org/10.1182/blood.2019003186

Published: 2020

Includes: Supplemental data

Journal Articles

Establishing a Novel in Vitro Informed Precision Clinical Trial Pathway for Refractory Pediatric Leukemia

Chunfen Zhang, MD, Ritul Sharma, MSc., Thakur Satbir, PhD, Allison Cheney, Olena Vaske, PhD, Lauren Sanders, Jessica Boklan, MD, Victor A. Lewis, MD, Ronald Anderson, MDFRCPC, Olga Kovalchuk, MD, PhD, Norman J. Lacayo, MD, Aru Narendran, MD PhD, Kevin J. Bielamowicz, MD

Blood (2019) 134 (Supplement_1): 2633.

https://doi.org/10.1182/blood-2019-131444

Published: 2019

Journal Articles

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria

Blood (2019) 134 (3): 304–316.

https://doi.org/10.1182/blood.2019000216

Published: 2019

Includes: Supplemental data

Journal Articles

Early Prediction of Moderate-Severe Chronic GvHD By Immunity Related Transcriptome

Amit Kalra, MBBS, MSc, Poonam Dharmani-Khan, PhD, Stuti Patel, BHSc, Rehan Mujeeb Faridi, PhD, Victor A. Lewis, MD, Andrew Daly, MD, Adnan Mansoor, MDPhD, Meer-Taher Shabani-Rad, MD, Jan Storek, MD PhD, Faisal M Khan, PhD D (ABHI)

Blood (2018) 132 (Supplement 1): 70.

https://doi.org/10.1182/blood-2018-99-119926

Published: 2018

Journal Articles

Alemtuzumab/Low Dose TBI Conditioning Facilitates Stable Long-Term Donor Hematopoietic Cell Engraftment from Sibling Donors in Children with Sickle Cell Disease

Gregory M Guilcher, MDBSc,FRCPC, Dania Monagel, MDFRCPC,FAAP, Michael Leaker, MDFRCPC, Tony H Truong, MDFRCPC, Alberto Nettel-Aguirre, PhD PStat, Aisha Bruce, MD, Catherine Corriveau-Bourque, MD, Sunil Desai, MD, Victor A. Lewis, MD

Blood (2017) 130 (Supplement 1): 4592.

https://doi.org/10.1182/blood.V130.Suppl_1.4592.4592

Published: 2017

Journal Articles

Functional GSTA1 Haplotypes Affect Clearance and Toxicity of Busulfan When Administered in 16 Doses to Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Multicenter Prospective Study on Behalf of the Pediatric Disease Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Blood (2016) 128 (22): 665.

https://doi.org/10.1182/blood.V128.22.665.665

Published: 2016

Journal Articles

Copies of Donor Killer Immunoglobulin-like Receptor Genes and Motifs Titrate Natural Killer (NK) Cells' Functional Response to Epstein - Barr Virus Infections and Influence the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Cell Transplantation

Rehan Mujeeb Faridi, PhD, Taylor J Kemp, B.HSc, Poonam Dharmani, PhD, Victor A. Lewis, MD, Noureddine Berka, PhD D (ABHI), Jan Storek, MD PhD, Faisal M Khan, PhD D (ABHI)

Blood (2015) 126 (23): 741.

https://doi.org/10.1182/blood.V126.23.741.741

Published: 2015

Journal Articles

Genetic Determinants of Busulfan Clearance and Outcomes in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation- Result of a Multicentric Prospective Study on Behalf of the Pediatric Disease Working Party of the European Blood and Marrow Transplantation Group

Blood (2014) 124 (21): 424.

https://doi.org/10.1182/blood.V124.21.424.424

Published: 2014

Journal Articles

I n Vitro Growth Inhibition, Target Modulation and Drug Synergy In Pediatric Leukemia By The Novel Proteasome Inhibitor Carfilzomib

Aarthi Jayanthan, Yibing Ruan, PhD, Meaghan Hagerty, Ravi Shah, Tony Truong, MD, Victor A. Lewis, MD, Jessica Boklan, MD, Tanya Trippett, MD, Lia Gore, MD, Aru Narendran, MD, PhD

Blood (2013) 122 (21): 2673.

https://doi.org/10.1182/blood.V122.21.2673.2673

Published: 2013

Journal Articles

Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group

Thai Hoa Tran, Rochelle Yanofsky, MD, FRCP(C), Donna Johnston, MD, FRCPC, David Dix, MD, Biljana Gillmeister, Marie-Chantal Ethier, BSc, Carol Portwine, Victoria E. Price, MBChB, MD, David Mitchell, Sonia Cellot, MD, Victor A. Lewis, MD, Shayna Zelcer, MD, Mariana Silva, MD, Bruno Michon, MD, FRCPC, Lynette Bowes, MD, Kent Stobart, MD, MSC, Josee Brossard, MD, Joseph Beyene, PhD, Lillian Sung, MD, PhD

Blood (2013) 122 (21): 1415.

https://doi.org/10.1182/blood.V122.21.1415.1415

Published: 2013

Journal Articles

Donor-Recipient Matching For Killer Immunoglobulin-Like Receptor Genotypes Confers Protection Against Graft Versus Host Disease Without Affecting Disease Relapse After Allogeneic Hematopoietic Cell Transplantation

Rehan M Faridi, PhD, Taylor J Kemp, Victor A. Lewis, MD, Noureddine Berka, PhD, Jan Storek, MD, PhD, Faisal Khan, PhD

Blood (2013) 122 (21): 4628.

https://doi.org/10.1182/blood.V122.21.4628.4628

Published: 2013

Journal Articles

Cooperative Lethality of Polo-Like Kinases (PLK) and Aurora Kinases (AK) in Refractory Pediatric Leukemia

Aarthi Jayanthan, Todd Cooper, DO, Sandra E. Dunn, PhD, Victor A. Lewis, MD, Aru Narendran, MD, PhD

Blood (2012) 120 (21): 3573.

https://doi.org/10.1182/blood.V120.21.3573.3573

Published: 2012

Journal Articles

Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia

Blood (2012) 119 (25): 6155–6161.

https://doi.org/10.1182/blood-2012-01-405795

Published: 2012

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) for Neuroblastoma (NB): The CIBMTR Experience

Blood (2011) 118 (21): 3074.

https://doi.org/10.1182/blood.V118.21.3074.3074

Published: 2011

NARROW

Alberta Cellular and Immunotherapy (ACIT) 001, Updated Results of Decentralized Production of Second Generation, Anti-CD19/41BB/CD3z Chimeric Antigen Receptor (CAR) T-Cells in Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL)

Outcome of Infants Treated on Total Therapy for Infants with Acute Lymphoblastic Leukemia I: Results from a Non-Randomized Multi-Center Study

Alberta Cellular and Immunotherapy (ACIT) 001, Results of Decentralized Production of Second Generation, Anti-CD19/41BB/CD3z Chimeric Antigen Receptor (CAR) T-Cells in Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL)

Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease

Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study

A Novel Anti-Cancer Vaccine Approach for the Treatment of High-Risk Leukemia in Children

Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies

Establishing a Novel in Vitro Informed Precision Clinical Trial Pathway for Refractory Pediatric Leukemia

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria

Early Prediction of Moderate-Severe Chronic GvHD By Immunity Related Transcriptome

Alemtuzumab/Low Dose TBI Conditioning Facilitates Stable Long-Term Donor Hematopoietic Cell Engraftment from Sibling Donors in Children with Sickle Cell Disease

Copies of Donor Killer Immunoglobulin-like Receptor Genes and Motifs Titrate Natural Killer (NK) Cells' Functional Response to Epstein - Barr Virus Infections and Influence the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Cell Transplantation

Genetic Determinants of Busulfan Clearance and Outcomes in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation- Result of a Multicentric Prospective Study on Behalf of the Pediatric Disease Working Party of the European Blood and Marrow Transplantation Group

I n Vitro Growth Inhibition, Target Modulation and Drug Synergy In Pediatric Leukemia By The Novel Proteasome Inhibitor Carfilzomib

Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group

Donor-Recipient Matching For Killer Immunoglobulin-Like Receptor Genotypes Confers Protection Against Graft Versus Host Disease Without Affecting Disease Relapse After Allogeneic Hematopoietic Cell Transplantation

Cooperative Lethality of Polo-Like Kinases (PLK) and Aurora Kinases (AK) in Refractory Pediatric Leukemia

Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia

Allogeneic Hematopoietic Cell Transplantation (HCT) for Neuroblastoma (NB): The CIBMTR Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only